Eritrea
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
4.32 (3.47 - 5.21) | 2019 | Modelled | IHME |
4.32 (3.48 - 5.20) | 2018 | Modelled | IHME |
4.33 (3.47 - 5.26) | 2017 | Modelled | IHME |
4.68 (3.80 - 5.71) | 2016 | Modelled | IHME |
5.13 (4.16 - 6.28) | 2015 | Modelled | IHME |
5.31 (4.29 - 6.47) | 2014 | Modelled | IHME |
5.45 (4.39 - 6.58) | 2013 | Modelled | IHME |
5.57 (4.45 - 6.69) | 2012 | Modelled | IHME |
5.67 (4.54 - 6.84) | 2011 | Modelled | IHME |
5.79 (4.59 - 7.04) | 2010 | Modelled | IHME |
5.92 (4.74 - 7.18) | 2009 | Modelled | IHME |
6.04 (4.83 - 7.33) | 2008 | Modelled | IHME |
6.17 (4.95 - 7.48) | 2007 | Modelled | IHME |
6.3 (5.05 - 7.70) | 2006 | Modelled | IHME |
6.43 (5.15 - 7.90) | 2005 | Modelled | IHME |
6.58 (5.28 - 8.05) | 2004 | Modelled | IHME |
6.75 (5.39 - 8.20) | 2003 | Modelled | IHME |
6.92 (5.54 - 8.39) | 2002 | Modelled | IHME |
7.07 (5.63 - 8.60) | 2001 | Modelled | IHME |
7.21 (5.71 - 8.84) | 2000 | Modelled | IHME |
7.33 (5.79 - 8.99) | 1999 | Modelled | IHME |
7.45 (5.90 - 9.18) | 1998 | Modelled | IHME |
7.55 (5.99 - 9.30) | 1997 | Modelled | IHME |
7.64 (6.02 - 9.49) | 1996 | Modelled | IHME |
7.71 (6.08 - 9.62) | 1995 | Modelled | IHME |
7.76 (6.14 - 9.54) | 1994 | Modelled | IHME |
7.8 (6.14 - 9.52) | 1993 | Modelled | IHME |
7.84 (6.15 - 9.57) | 1992 | Modelled | IHME |
7.87 (6.21 - 9.54) | 1991 | Modelled | IHME |
7.88 (6.21 - 9.53) | 1990 | Modelled | IHME |
1.85 (1.49 - 2.27) | 2015 | Modelled | WHO |
2.49 (2.32 - 2.67) | 2013 | Modelled | Schweitzer et al, 2015 |
Showing out of
Show more
Children under-5 years
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.42 (0.29 - 0.57) | 2019 | Modelled | IHME |
0.45 (0.32 - 0.61) | 2018 | Modelled | IHME |
0.47 (0.33 - 0.64) | 2017 | Modelled | IHME |
0.5 (0.35 - 0.66) | 2016 | Modelled | IHME |
0.51 (0.37 - 0.69) | 2015 | Modelled | IHME |
0.53 (0.38 - 0.72) | 2014 | Modelled | IHME |
0.55 (0.39 - 0.74) | 2013 | Modelled | IHME |
0.56 (0.40 - 0.76) | 2012 | Modelled | IHME |
0.58 (0.40 - 0.78) | 2011 | Modelled | IHME |
0.59 (0.41 - 0.80) | 2010 | Modelled | IHME |
0.59 (0.41 - 0.80) | 2009 | Modelled | IHME |
0.6 (0.42 - 0.81) | 2008 | Modelled | IHME |
0.6 (0.43 - 0.81) | 2007 | Modelled | IHME |
0.61 (0.43 - 0.82) | 2006 | Modelled | IHME |
0.62 (0.44 - 0.83) | 2005 | Modelled | IHME |
1.01 (0.73 - 1.33) | 2004 | Modelled | IHME |
1.93 (1.40 - 2.52) | 2003 | Modelled | IHME |
3.04 (2.21 - 3.99) | 2002 | Modelled | IHME |
4.01 (2.90 - 5.27) | 2001 | Modelled | IHME |
4.51 (3.23 - 6.03) | 2000 | Modelled | IHME |
4.64 (3.32 - 6.18) | 1999 | Modelled | IHME |
4.73 (3.40 - 6.33) | 1998 | Modelled | IHME |
4.81 (3.45 - 6.44) | 1997 | Modelled | IHME |
4.86 (3.46 - 6.57) | 1996 | Modelled | IHME |
4.9 (3.50 - 6.68) | 1995 | Modelled | IHME |
4.94 (3.56 - 6.66) | 1994 | Modelled | IHME |
4.98 (3.59 - 6.61) | 1993 | Modelled | IHME |
5 (3.62 - 6.61) | 1992 | Modelled | IHME |
5.03 (3.68 - 6.64) | 1991 | Modelled | IHME |
5.04 (3.71 - 6.71) | 1990 | Modelled | IHME |
0.74 (0.49 - 1.05) | 2015 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
236,488 (186,406 - 285,981) | 1990 | Modelled | IHME |
232,726 (183,631 - 282,163) | 1991 | Modelled | IHME |
243,471 (190,956 - 297,207) | 1992 | Modelled | IHME |
255,552 (201,014 - 311,873) | 1993 | Modelled | IHME |
266,797 (211,138 - 328,315) | 1994 | Modelled | IHME |
275,495 (217,464 - 343,787) | 1995 | Modelled | IHME |
281,378 (221,725 - 349,343) | 1996 | Modelled | IHME |
286,186 (226,908 - 352,457) | 1997 | Modelled | IHME |
289,168 (229,201 - 356,430) | 1998 | Modelled | IHME |
291,060 (229,941 - 357,197) | 1999 | Modelled | IHME |
295,382 (234,064 - 362,065) | 2000 | Modelled | IHME |
303,797 (241,838 - 369,472) | 2001 | Modelled | IHME |
313,200 (250,707 - 380,131) | 2002 | Modelled | IHME |
317,860 (253,950 - 386,203) | 2003 | Modelled | IHME |
318,831 (255,561 - 389,724) | 2004 | Modelled | IHME |
319,972 (256,104 - 393,041) | 2005 | Modelled | IHME |
321,770 (257,916 - 393,484) | 2006 | Modelled | IHME |
324,168 (260,066 - 393,189) | 2007 | Modelled | IHME |
326,048 (260,756 - 395,351) | 2008 | Modelled | IHME |
327,123 (261,794 - 397,120) | 2009 | Modelled | IHME |
327,274 (259,712 - 398,203) | 2010 | Modelled | IHME |
327,320 (261,873 - 394,694) | 2011 | Modelled | IHME |
327,250 (261,545 - 393,143) | 2012 | Modelled | IHME |
325,671 (262,309 - 393,021) | 2013 | Modelled | IHME |
322,322 (260,257 - 392,596) | 2014 | Modelled | IHME |
316,395 (256,551 - 387,440) | 2015 | Modelled | IHME |
293,889 (238,746 - 358,368) | 2016 | Modelled | IHME |
277,580 (222,126 - 337,102) | 2017 | Modelled | IHME |
283,370 (228,157 - 340,644) | 2018 | Modelled | IHME |
290,106 (233,157 - 349,521) | 2019 | Modelled | IHME |
Showing out of
Show more
HBV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
4.58 (2.88 - 6.86) | 2019 | Modelled | IHME |
4.56 (2.85 - 6.90) | 2018 | Modelled | IHME |
4.54 (2.83 - 6.88) | 2017 | Modelled | IHME |
4.5 (2.78 - 6.86) | 2016 | Modelled | IHME |
4.5 (2.82 - 6.86) | 2015 | Modelled | IHME |
4.71 (2.87 - 7.15) | 2014 | Modelled | IHME |
5.23 (3.25 - 7.97) | 2013 | Modelled | IHME |
5.8 (3.58 - 8.83) | 2012 | Modelled | IHME |
6.27 (3.86 - 9.56) | 2011 | Modelled | IHME |
6.51 (4.03 - 9.96) | 2010 | Modelled | IHME |
6.52 (4.06 - 9.94) | 2009 | Modelled | IHME |
6.5 (4.02 - 9.84) | 2008 | Modelled | IHME |
6.45 (3.90 - 9.77) | 2007 | Modelled | IHME |
6.46 (3.89 - 9.82) | 2006 | Modelled | IHME |
6.45 (3.89 - 9.86) | 2005 | Modelled | IHME |
6.47 (3.88 - 9.91) | 2004 | Modelled | IHME |
6.47 (3.95 - 9.92) | 2003 | Modelled | IHME |
6.56 (4 - 9.97) | 2002 | Modelled | IHME |
6.51 (3.98 - 9.88) | 2001 | Modelled | IHME |
6.68 (4.10 - 10) | 2000 | Modelled | IHME |
6.63 (4.08 - 9.89) | 1999 | Modelled | IHME |
6.53 (4.07 - 9.76) | 1998 | Modelled | IHME |
6.59 (4.10 - 9.85) | 1997 | Modelled | IHME |
6.57 (4.03 - 9.96) | 1996 | Modelled | IHME |
6.58 (4.03 - 10.10) | 1995 | Modelled | IHME |
6.27 (3.88 - 9.46) | 1994 | Modelled | IHME |
6.12 (3.76 - 9.28) | 1993 | Modelled | IHME |
6.09 (3.74 - 9.25) | 1992 | Modelled | IHME |
6.09 (3.69 - 9.53) | 1991 | Modelled | IHME |
6.02 (3.61 - 9.36) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
307 (193 - 460) | 2019 | Modelled | IHME |
299 (187 - 453) | 2018 | Modelled | IHME |
291 (181 - 441) | 2017 | Modelled | IHME |
282 (174 - 431) | 2016 | Modelled | IHME |
277 (174 - 423) | 2015 | Modelled | IHME |
285 (174 - 434) | 2014 | Modelled | IHME |
313 (194 - 476) | 2013 | Modelled | IHME |
341 (210 - 519) | 2012 | Modelled | IHME |
362 (223 - 552) | 2011 | Modelled | IHME |
368 (228 - 563) | 2010 | Modelled | IHME |
360 (225 - 550) | 2009 | Modelled | IHME |
351 (217 - 531) | 2008 | Modelled | IHME |
339 (205 - 513) | 2007 | Modelled | IHME |
330 (199 - 502) | 2006 | Modelled | IHME |
321 (194 - 490) | 2005 | Modelled | IHME |
313 (188 - 480) | 2004 | Modelled | IHME |
305 (186 - 467) | 2003 | Modelled | IHME |
297 (181 - 452) | 2002 | Modelled | IHME |
280 (171 - 425) | 2001 | Modelled | IHME |
274 (168 - 411) | 2000 | Modelled | IHME |
263 (162 - 393) | 1999 | Modelled | IHME |
254 (158 - 379) | 1998 | Modelled | IHME |
250 (155 - 373) | 1997 | Modelled | IHME |
242 (148 - 367) | 1996 | Modelled | IHME |
235 (144 - 362) | 1995 | Modelled | IHME |
216 (133 - 325) | 1994 | Modelled | IHME |
201 (123 - 304) | 1993 | Modelled | IHME |
189 (116 - 287) | 1992 | Modelled | IHME |
180 (109 - 282) | 1991 | Modelled | IHME |
181 (108 - 281) | 1990 | Modelled | IHME |
371 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
32 (25 - 40) | 2019 | Modelled | IHME |
32 (25 - 41) | 2018 | Modelled | IHME |
32 (25 - 40) | 2017 | Modelled | IHME |
32 (24 - 40) | 2016 | Modelled | IHME |
32 (24 - 41) | 2015 | Modelled | IHME |
32 (25 - 41) | 2014 | Modelled | IHME |
32 (25 - 41) | 2013 | Modelled | IHME |
33 (25 - 42) | 2012 | Modelled | IHME |
33 (26 - 42) | 2011 | Modelled | IHME |
33 (26 - 42) | 2010 | Modelled | IHME |
33 (26 - 43) | 2009 | Modelled | IHME |
33 (26 - 43) | 2008 | Modelled | IHME |
33 (26 - 43) | 2007 | Modelled | IHME |
33 (26 - 43) | 2006 | Modelled | IHME |
33 (26 - 42) | 2005 | Modelled | IHME |
33 (26 - 43) | 2004 | Modelled | IHME |
34 (26 - 43) | 2003 | Modelled | IHME |
34 (26 - 43) | 2002 | Modelled | IHME |
34 (26 - 43) | 2001 | Modelled | IHME |
34 (27 - 44) | 2000 | Modelled | IHME |
34 (27 - 44) | 1999 | Modelled | IHME |
34 (27 - 44) | 1998 | Modelled | IHME |
35 (27 - 45) | 1997 | Modelled | IHME |
35 (27 - 45) | 1996 | Modelled | IHME |
35 (27 - 45) | 1995 | Modelled | IHME |
35 (27 - 45) | 1994 | Modelled | IHME |
35 (27 - 45) | 1993 | Modelled | IHME |
35 (27 - 45) | 1992 | Modelled | IHME |
35 (27 - 45) | 1991 | Modelled | IHME |
35 (27 - 45) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
95 | 2019 | Survey/reported | WHO/UNICEF |
95 | 2020 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
1.7 (1.36 - 2.14) | 2019 | Modelled | IHME |
1.7 (1.36 - 2.13) | 2018 | Modelled | IHME |
1.7 (1.36 - 2.12) | 2017 | Modelled | IHME |
1.69 (1.36 - 2.11) | 2016 | Modelled | IHME |
1.68 (1.35 - 2.08) | 2015 | Modelled | IHME |
1.68 (1.35 - 2.09) | 2014 | Modelled | IHME |
1.68 (1.35 - 2.10) | 2013 | Modelled | IHME |
1.68 (1.35 - 2.10) | 2012 | Modelled | IHME |
1.68 (1.35 - 2.10) | 2011 | Modelled | IHME |
1.68 (1.34 - 2.11) | 2010 | Modelled | IHME |
1.68 (1.35 - 2.10) | 2009 | Modelled | IHME |
1.67 (1.35 - 2.09) | 2008 | Modelled | IHME |
1.67 (1.35 - 2.09) | 2007 | Modelled | IHME |
1.66 (1.34 - 2.09) | 2006 | Modelled | IHME |
1.66 (1.33 - 2.08) | 2005 | Modelled | IHME |
1.66 (1.34 - 2.08) | 2004 | Modelled | IHME |
1.67 (1.34 - 2.08) | 2003 | Modelled | IHME |
1.67 (1.35 - 2.07) | 2002 | Modelled | IHME |
1.68 (1.35 - 2.08) | 2001 | Modelled | IHME |
1.68 (1.35 - 2.09) | 2000 | Modelled | IHME |
1.69 (1.36 - 2.10) | 1999 | Modelled | IHME |
1.69 (1.36 - 2.11) | 1998 | Modelled | IHME |
1.7 (1.37 - 2.12) | 1997 | Modelled | IHME |
1.71 (1.37 - 2.14) | 1996 | Modelled | IHME |
1.72 (1.37 - 2.17) | 1995 | Modelled | IHME |
1.73 (1.38 - 2.17) | 1994 | Modelled | IHME |
1.74 (1.39 - 2.19) | 1993 | Modelled | IHME |
1.76 (1.40 - 2.21) | 1992 | Modelled | IHME |
1.77 (1.41 - 2.24) | 1991 | Modelled | IHME |
1.79 (1.42 - 2.26) | 1990 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.86 (0.66 - 1.15) | 2019 | Modelled | Dugan et al., 2021 |
Number of people living with chronic HCV (RNA+/cAg)
National
DownloadValue | Year | Type | Source |
---|---|---|---|
53,582 (42,670 - 67,800) | 1990 | Modelled | IHME |
52,391 (41,781 - 66,280) | 1991 | Modelled | IHME |
54,569 (43,540 - 68,670) | 1992 | Modelled | IHME |
57,130 (45,464 - 71,734) | 1993 | Modelled | IHME |
59,583 (47,604 - 74,781) | 1994 | Modelled | IHME |
61,543 (49,086 - 77,389) | 1995 | Modelled | IHME |
63,033 (50,442 - 78,647) | 1996 | Modelled | IHME |
64,516 (51,984 - 80,371) | 1997 | Modelled | IHME |
65,795 (52,928 - 81,783) | 1998 | Modelled | IHME |
66,998 (53,926 - 83,245) | 1999 | Modelled | IHME |
68,905 (55,389 - 85,716) | 2000 | Modelled | IHME |
72,015 (57,944 - 89,495) | 2001 | Modelled | IHME |
75,709 (61,002 - 93,863) | 2002 | Modelled | IHME |
78,535 (63,103 - 98,046) | 2003 | Modelled | IHME |
80,601 (64,880 - 100,837) | 2004 | Modelled | IHME |
82,732 (66,363 - 103,550) | 2005 | Modelled | IHME |
85,066 (68,362 - 106,546) | 2006 | Modelled | IHME |
87,677 (70,728 - 109,803) | 2007 | Modelled | IHME |
90,245 (72,667 - 113,010) | 2008 | Modelled | IHME |
92,656 (74,491 - 116,041) | 2009 | Modelled | IHME |
94,839 (75,998 - 119,256) | 2010 | Modelled | IHME |
96,817 (77,760 - 121,430) | 2011 | Modelled | IHME |
98,606 (79,218 - 123,293) | 2012 | Modelled | IHME |
100,125 (80,459 - 125,253) | 2013 | Modelled | IHME |
101,667 (81,928 - 126,473) | 2014 | Modelled | IHME |
103,397 (83,457 - 128,470) | 2015 | Modelled | IHME |
105,933 (85,686 - 132,377) | 2016 | Modelled | IHME |
108,892 (87,191 - 136,200) | 2017 | Modelled | IHME |
111,593 (89,463 - 139,822) | 2018 | Modelled | IHME |
114,314 (91,262 - 143,329) | 2019 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue | Year | Type | Source |
---|---|---|---|
7,100 (5,500 - 9,400) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
DownloadValue (Deaths per 100,000) | Year | Type | Source |
---|---|---|---|
9.12 (6.15 - 13.20) | 2019 | Modelled | IHME |
9.05 (6.09 - 13.20) | 2018 | Modelled | IHME |
9 (6.03 - 13.10) | 2017 | Modelled | IHME |
8.9 (5.94 - 12.90) | 2016 | Modelled | IHME |
8.88 (5.89 - 13) | 2015 | Modelled | IHME |
8.72 (5.78 - 12.70) | 2014 | Modelled | IHME |
8.49 (5.65 - 12.30) | 2013 | Modelled | IHME |
8.19 (5.40 - 11.90) | 2012 | Modelled | IHME |
7.99 (5.22 - 11.70) | 2011 | Modelled | IHME |
7.97 (5.18 - 11.80) | 2010 | Modelled | IHME |
7.97 (5.22 - 12) | 2009 | Modelled | IHME |
7.96 (5.24 - 11.90) | 2008 | Modelled | IHME |
7.92 (5.15 - 11.80) | 2007 | Modelled | IHME |
7.93 (5.14 - 11.90) | 2006 | Modelled | IHME |
7.92 (5.12 - 11.80) | 2005 | Modelled | IHME |
7.9 (5.08 - 11.80) | 2004 | Modelled | IHME |
7.81 (5.03 - 11.60) | 2003 | Modelled | IHME |
7.78 (5.04 - 11.50) | 2002 | Modelled | IHME |
7.62 (4.91 - 11.10) | 2001 | Modelled | IHME |
7.74 (5.03 - 11.30) | 2000 | Modelled | IHME |
7.67 (5 - 11.10) | 1999 | Modelled | IHME |
7.55 (4.85 - 11) | 1998 | Modelled | IHME |
7.6 (4.84 - 11.10) | 1997 | Modelled | IHME |
7.56 (4.78 - 11.20) | 1996 | Modelled | IHME |
7.56 (4.70 - 11.10) | 1995 | Modelled | IHME |
7.21 (4.55 - 10.70) | 1994 | Modelled | IHME |
7.04 (4.44 - 10.50) | 1993 | Modelled | IHME |
7 (4.34 - 10.60) | 1992 | Modelled | IHME |
7.01 (4.24 - 10.60) | 1991 | Modelled | IHME |
6.92 (4.14 - 10.60) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
612 (413 - 886) | 2019 | Modelled | IHME |
594 (399 - 865) | 2018 | Modelled | IHME |
577 (386 - 839) | 2017 | Modelled | IHME |
559 (373 - 813) | 2016 | Modelled | IHME |
547 (364 - 801) | 2015 | Modelled | IHME |
529 (350 - 772) | 2014 | Modelled | IHME |
507 (338 - 735) | 2013 | Modelled | IHME |
482 (318 - 700) | 2012 | Modelled | IHME |
461 (301 - 674) | 2011 | Modelled | IHME |
450 (293 - 666) | 2010 | Modelled | IHME |
441 (289 - 661) | 2009 | Modelled | IHME |
430 (283 - 644) | 2008 | Modelled | IHME |
416 (271 - 619) | 2007 | Modelled | IHME |
405 (262 - 606) | 2006 | Modelled | IHME |
394 (254 - 588) | 2005 | Modelled | IHME |
382 (246 - 569) | 2004 | Modelled | IHME |
368 (237 - 548) | 2003 | Modelled | IHME |
353 (228 - 522) | 2002 | Modelled | IHME |
327 (211 - 477) | 2001 | Modelled | IHME |
317 (206 - 462) | 2000 | Modelled | IHME |
305 (198 - 441) | 1999 | Modelled | IHME |
293 (188 - 427) | 1998 | Modelled | IHME |
288 (183 - 421) | 1997 | Modelled | IHME |
278 (176 - 411) | 1996 | Modelled | IHME |
270 (168 - 398) | 1995 | Modelled | IHME |
248 (157 - 369) | 1994 | Modelled | IHME |
231 (145 - 344) | 1993 | Modelled | IHME |
218 (135 - 329) | 1992 | Modelled | IHME |
207 (125 - 315) | 1991 | Modelled | IHME |
208 (124 - 319) | 1990 | Modelled | IHME |
291 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
23 (16 - 31) | 2019 | Modelled | IHME |
23 (16 - 31) | 2018 | Modelled | IHME |
23 (16 - 31) | 2017 | Modelled | IHME |
23 (16 - 31) | 2016 | Modelled | IHME |
23 (16 - 31) | 2015 | Modelled | IHME |
22 (16 - 30) | 2014 | Modelled | IHME |
22 (15 - 30) | 2013 | Modelled | IHME |
22 (15 - 30) | 2012 | Modelled | IHME |
22 (15 - 30) | 2011 | Modelled | IHME |
22 (15 - 29) | 2010 | Modelled | IHME |
22 (15 - 29) | 2009 | Modelled | IHME |
21 (15 - 29) | 2008 | Modelled | IHME |
21 (15 - 29) | 2007 | Modelled | IHME |
21 (15 - 29) | 2006 | Modelled | IHME |
21 (14 - 29) | 2005 | Modelled | IHME |
21 (14 - 28) | 2004 | Modelled | IHME |
21 (14 - 28) | 2003 | Modelled | IHME |
21 (14 - 28) | 2002 | Modelled | IHME |
20 (14 - 28) | 2001 | Modelled | IHME |
20 (13 - 28) | 2000 | Modelled | IHME |
20 (13 - 28) | 1999 | Modelled | IHME |
20 (13 - 28) | 1998 | Modelled | IHME |
20 (13 - 28) | 1997 | Modelled | IHME |
20 (13 - 28) | 1996 | Modelled | IHME |
20 (13 - 28) | 1995 | Modelled | IHME |
20 (13 - 28) | 1994 | Modelled | IHME |
20 (13 - 28) | 1993 | Modelled | IHME |
20 (13 - 28) | 1992 | Modelled | IHME |
20 (13 - 28) | 1991 | Modelled | IHME |
20 (13 - 28) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Prevalence < 5
HBV
0.42
(%)
2019, latest modelled
(0.29 - 0.57(%))
IHME
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
No. of syringes/PWID/year
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines